Re:Mylan overcharged Medicaid for EpiPen for years, despite ...
by martijn_himself on Friday October 07, 2016 @10:47AM
(#12661053)
I agree my comment was a silly attempt to illustrate that a free market will set a price that may be considered 'unfair' in some cases. However the EpiPen market seems to be far from free.
Those players aren't being made possible by the patent system and medical regulatory agencies though. If you can play soccer better than them you can go take their position, but if you make a cheaper EpiPen you won't be able to compete. (Though that may be changing, the FDA seems ready to fast track some competitors.)